PhoreMost enters multi-target collaboration with targeted protein degradation leader Arvinas 28th October 2022
NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics 11th January 2022
PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies 5th January 2022